Northwest Biotherapeutics (NWBO) Retained Earnings (2010 - 2026)
Northwest Biotherapeutics' (NWBO) quarterly Retained Earnings came in at -$429000.0 in Q1 2026, up 99.97% year-on-year from -$214531.5 in Q1 2025, and up 53.62% quarter-over-quarter from -$925000.0 in Q4 2025.
Northwest Biotherapeutics (NWBO) Retained Earnings (2010 - 2026) Analysis & Trends
Northwest Biotherapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at -$429000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.97% year-over-year to -$429000.0 in Q1 2026; TTM through Mar 2026 was -$429000.0, a 99.97% increase from a year earlier, with the FY2025 full-year figure at -$925000.0, up 99.94% from the prior year.
- Retained Earnings climbed to -$429000.0 in Q1 2026 per NWBO's latest filing, from -$925000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $6.3 million in Q3 2022 and bottomed at -$1.5 billion in Q1 2025.
- The 5-year median for Retained Earnings is -$925000.0 (2025), against an average of -$483.1 million.
- Across the five-year window, Retained Earnings soared 543.61% in 2022 and sank 68139.16% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$1.3 billion in 2022, then dropped by 4.83% to -$1.4 billion in 2023, then declined by 6.16% to -$1.4 billion in 2024, then surged by 99.94% to -$925000.0 in 2025, then jumped by 53.62% to -$429000.0 in 2026.
- Per Business Quant, the three latest NWBO Retained Earnings figures stand at -$429000.0 (Q1 2026), -$925000.0 (Q4 2025), and -$1.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - | -429,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -429,000.00 |
| Dec 31, 2025 | -925,000.00 |
| Sep 30, 2025 | -1.22 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | -1.46 Bn |
| Dec 31, 2024 | -1.44 Bn |
| Sep 30, 2024 | -29,000.00 |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | -1.36 Bn |
| Sep 30, 2023 | -1.34 Bn |
| Jun 30, 2023 | -1.32 Bn |
| Mar 31, 2023 | 2.40 Mn |
| Dec 31, 2022 | -1.30 Bn |
| Sep 30, 2022 | 6.31 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | -1.19 Bn |
| Sep 30, 2021 | -1.33 Bn |
| Jun 30, 2021 | -798,000.00 |